A newer wave of lawsuits has focused on when emergency medical exceptions to abortion bans apply and whether states can stop their citizens from traveling to states where abortion remains legal—a trend experts expect to continue in the new year.
Tag Archive for: U.S. Supreme Court
The U.S. Supreme Court on Monday declined to hear a lawsuit by CareDx over organ-rejection tests made by Natera and Eurofins Viracor, turning down another request to revisit the contentious issue of patent eligibility.
Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare over the prices of selected costly drugs may not have a clear legal precedent on their side, but there are signs they could get a friendly hearing from the U.S. Supreme Court, legal experts said.
The U.S. Supreme Court on Friday preserved the Justice Department’s power to unilaterally dismiss lawsuits filed under a law that lets whistleblowers sue businesses on behalf of the government to recover taxpayer money paid to companies based on false claims in exchange for a portion of any recovery.
The U.S. Supreme Court on Thursday gave a boost to whistleblowers in their bid to revive lawsuits accusing pharmacy operators of knowingly overbilling government health insurance programs for prescription drugs at taxpayers’ expense.
The justices turned away Israel-based Teva’s appeal of a lower court’s ruling reinstating the jury award for U.K.-based GSK. The case involves “skinny labels,” which allow generic drugmakers to avoid patent lawsuits if a generic drug’s label omits potentially infringing uses of a brand-name drug.
The U.S. Supreme Court on Friday blocked new restrictions set by lower courts on a widely used abortion pill, a decision welcomed by President Joe Biden as his administration defends broad access to the drug in the latest fierce legal battle over reproductive rights in the United States.
U.S. Supreme Court Justice Samuel Alito on Wednesday extended by two days a temporary block on limits set by lower courts on access to the abortion pill mifepristone in a challenge by anti-abortion groups to the drug’s federal regulatory approval.
The U.S. Supreme Court on Tuesday considered a bid by three whistleblowers to revive lawsuits accusing pharmacy operators of pocketing millions of taxpayer dollars by knowingly overbilling government health insurance programs for prescription drugs.
The U.S. Supreme Court on Monday declined to hear Novartis Pharmaceuticals Corp.’s bid to revive a key patent on its blockbuster multiple sclerosis drug Gilenya that was invalidated amid a legal dispute with China’s HEC Pharm Co. Ltd.